Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaLiver TransplantationTransplantation ChimeraHematopoietic Stem CellsGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingStem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesMice, Inbred C57BLKidney TransplantationHematopoiesisStem Cell TransplantationRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsTime FactorsTreatment OutcomeHematologic NeoplasmsGraft RejectionRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsImmunosuppressionT-LymphocytesGraft vs Host ReactionLeukemia, MyeloidLymphocyte DepletionAcute DiseaseLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationColony-Forming Units AssaySevere Combined ImmunodeficiencyChimeraHLA AntigensSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCell DifferentiationCyclosporineHematologic DiseasesLymphocyte TransfusionBone DensityActuarial AnalysisMice, Inbred BALB CSpleenCells, CulturedAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryNuclear FamilyCarmustineOrgan TransplantationLeukocyte CountPancytopeniaGraft vs Tumor EffectFollow-Up StudiesGraft vs Leukemia EffectCytomegalovirus InfectionsSurvival RateCytarabineGranulocyte Colony-Stimulating FactorImmune SystemMice, KnockoutBone ResorptionMelphalanDisease-Free SurvivalEtoposideImmune ToleranceMultiple MyelomaLymphomaAntigens, CD34Fatal OutcomeCord Blood Stem Cell TransplantationCell TransplantationInfection